FundingWatcher
Home / Startups / Top biotech startups / Biotech startups in Japan

Biotech startups in Japan

Updated 16 Nov 2026

Reset
Biotech startups in Japan
One-time CSV
  • 129 funded companies, 89 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech~japan.csv129 rows × 18 columns
CompanyCityLast roundAmountDate
Celaid TherapeuticsTokyoSeries B$2.5M2026-10-05
DioseveTokyoSeries A$6.2M2026-06-11
Restore VisionTokyoSeries B$8.2M2026-04-15
ThinkCyteHongoSeries C$14.8M2024-08-29
Red Arrow TherapeuticsMinatoSeed$4.5M2024-04-23
BioPhenoMATokyoSeed$1.2M2024-11-07
HACARUSKyotoSeries B$12.4M2020-11-16
GRA&GREENNagoyaSeries C$4.1M2024-06-21

8 rows of the CSV in 5 of its 18 columns.

129
Startups
$813.0M
Total raised
22
Funded in the last 12 months
$90.5M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

9 of 129
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
Celaid Therapeutics Celaid Therapeutics develops cell therapies for blood cancer, intractable blood diseases, and genetic disorders. Biotech Tokyo Series B $2.5M 2026-10-05 $17.1M UTEC - The University of Tokyo Edge Capital Partners, Osaka University Venture Capital, Joyo Capital Partners 1 to 10 2020
Dioseve Dioseve produces egg cells using DIOLs to create more reproductive possibilities. Biotech Tokyo Series A $6.2M 2026-06-11 $15.5M ANRI, Coral Capital, Archetype Ventures +2 11 to 50 2021
Restore Vision Restore Vision develops a gene therapy to restore vision for patients with retinitis pigmentosa. Biotech Tokyo Series B $8.2M 2026-04-15 $26.7M SMBC Venture Capital, ANRI, Spiral Capital +2 1 to 10 2016
ThinkCyte ThinkCyte is a biotechnology company that sorts cells for research, diagnostics, and therapeutics. Biotech Hongo Series C $14.8M 2024-08-29 SMBC Venture Capital, SkyDeck Berkeley, Berkeley SkyDeck Fund 51 to 100 2016
GRA&GREEN GRA&GREEN develops seeds for agriculture and forestry and supplies raw materials for food processing. Biotech Nagoya Series C $4.1M 2024-06-21 Mitsubishi UFJ Capital, Mizuho Capital, Beyond Next Ventures +1 11 to 50 2017
Red Arrow Therapeutics Red Arrow Therapeutics is a biotech firm developing systemic cytokine delivery and targeted intratumoral activation. Biotech Minato Seed $4.5M 2024-04-23 MassChallenge, UTEC - The University of Tokyo Edge Capital Partners, Beyond Next Ventures +2 11 to 50 2021
Ac-Planta Ac-Planta develops, manufactures, and sells biostimulant materials for agriculture. Biotech Tokyo Series A $3.2M 2024-03-15 Global Brain Corporation, SMBC Venture Capital, SVG Ventures +1 1 to 10 2018
Genoplan Genoplan provides DNA testing and genetic analysis services. Artificial intelligence Fukuoka Series C $9.2M 2020-12-28 SBVA, SparkLabs Accelerator, Samsung Ventures +1 11 to 50 2014
HACARUS Hacarus is a medical technology company that uses AI to develop check series and workplace safety tools. Artificial intelligence Kyoto Series B $12.4M 2020-11-16 $24.3M Miraidoa, Resona Capital, Miyako Capital +1 51 to 100 2014

Table 1. Biotech startups in Japan: the 9 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 129.

Largest rounds

Last 12 months
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 Restore Vision Restore Vision develops a gene therapy to restore vision for patients with retinitis pigmentosa. Biotech Tokyo Series B $8.2M 2026-04-15 $26.7M SMBC Venture Capital, ANRI, Spiral Capital +2 1 to 10 2016
2 Dioseve Dioseve produces egg cells using DIOLs to create more reproductive possibilities. Biotech Tokyo Series A $6.2M 2026-06-11 $15.5M ANRI, Coral Capital, Archetype Ventures +2 11 to 50 2021
3 Celaid Therapeutics Celaid Therapeutics develops cell therapies for blood cancer, intractable blood diseases, and genetic disorders. Biotech Tokyo Series B $2.5M 2026-10-05 $17.1M UTEC - The University of Tokyo Edge Capital Partners, Osaka University Venture Capital, Joyo Capital Partners 1 to 10 2020

Table 2. Biotech startups in Japan: the 3 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 UTEC - The University of Tokyo Edge Capital Partners Venture capital firm Tokyo, Japan 5 4% 1 Celaid Therapeutics
2 ANRI Venture capital firm Tokyo, Japan 4 3% 3 Dioseve, Restore Vision, Cosomil
3 SMBC Venture Capital Corporate venture arm Tokyo, Japan 4 3% 1 Restore Vision
4 Spiral Capital Venture capital firm Tokyo, Japan 3 2% 2 Dioseve, Restore Vision
5 Beyond Next Ventures Startup accelerator Tokyo, Japan 3 2%
6 Mizuho Capital Venture capital firm Tokyo, Japan 3 2%
7 DG Daiwa Ventures Venture capital firm Marunouchi, Japan 3 2%
8 Osaka University Venture Capital Venture capital firm Osaka, Japan 2 2% 1 Celaid Therapeutics
9 Coral Capital Venture capital firm Tokyo, Japan 2 2% 2 Dioseve, Cosomil
10 SBI Investment Venture capital firm Minato, Japan 2 2%
11 Mitsubishi UFJ Capital Corporate venture arm Tokyo, Japan 2 2%
12 Global Brain Corporation Venture capital firm Tokyo, Japan 2 2%
13 UntroD Capital Venture capital firm Sumida, Japan 2 2%
14 Nissay Capital Venture capital firm Tokyo, Japan 2 2%
15 Joyo Capital Partners Venture capital firm 1 1% 1 Celaid Therapeutics

Table 3. Biotech startups in Japan: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 106 82% $800.1M
Software 17 13% $53.3M
Artificial intelligence 10 8% $52.2M
Hardware 4 3% $3.0M
Energy 2 2% $375K
Fintech 1 1%
Education 1 1% $15.4M
Cybersecurity 1 1%
Commerce 1 1% $135K

Table 4. Biotech startups in Japan by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Pre-seed 5 4% $150K
Seed 41 32% $700K
Series A 41 32% $5.5M
Series B 23 18% $8.6M
Series C 15 12% $10.2M
Series D+ 4 3% $7.9M

Table 5. Biotech startups in Japan by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Tokyo 47 36%
Kyoto 6 5%
Tsukuba 6 5%
Hongo 4 3%
Osaka 4 3%
Fujisawa 3 2%
Kawasaki 3 2%
Fukuoka 3 2%
Uruma 2 2%
Minato 2 2%
Tokushima 2 2%
Okinawa 2 2%

Table 6. Biotech startups in Japan by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 1 5% $700K
October 2026 2 9% $3.5M
September 2026 3 14% $9.3M
August 2026 2 9% $375K
July 2026 1 5% $2.2M
June 2026 3 14% $45.5M
May 2026 2 9% $13.3M
April 2026 4 18% $12.4M
February 2026 1 5%
January 2026 2 9% $2.2M
December 2025 1 5% $1.0M

Table 7. Biotech startups in Japan: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 21 16% $89.5M
2025 12 9% $67.9M
2024 22 17% $107.0M
2023 9 7% $42.9M
2022 9 7% $96.5M
2021 13 10% $84.1M

Table 8. Biotech startups in Japan by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 9 7%
2020 to 2022 31 25%
2015 to 2019 66 52%
2010 to 2014 11 9%
Before 2010 9 7%

Table 9. Biotech startups in Japan by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 45 38%
11 to 50 62 52%
51 to 100 7 6%
101 to 250 4 3%
1,001 to 5,000 1 1%

Table 10. Biotech startups in Japan by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in Japan are on the list?
129, in the file dated 16 November 2026. 22 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 129 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups in Japan: 129 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech startups in Japan by funding stage

Other sectors in Japan

Biotech startups elsewhere

Cite: FundingWatcher, 129 funded biotech companies in Japan, 16 November 2026. https://fundingwatcher.com/startups/biotech/japan/